Global Human Microbiome Market Size To Exceed USD 15.95 Billion By 2035 | CAGR of 31.42%
Category: HealthcareGlobal Human Microbiome Market Size To Exceed USD 15.95 Billion By 2035
According to a research report published by Spherical Insights & Consulting, the Global Human Microbiome Market is Expected to Grow from USD 0.79 Billion in 2024 to USD 15.95 Billion by 2035, at a CAGR of 31.42% during the forecast period 2025-2035.
Get more details on this report -
Browse key industry insights spread across 250 pages with 120 Market data tables and figures & charts from the report on the " Global Human Microbiome Market Size, Share, and COVID-19 Impact Analysis, By Product (Drugs, Probiotics, Prebiotics, and Synbiotics), By Disease (Infectious, Gastrointestinal, and Endocrine & Metabolic), By Type (BCT/FMT and Live Biotherapeutics), By End User (Hospitals & Clinics and Long-term Care), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035." Get Detailed Report Description Here:https://www.sphericalinsights.com/reports/human-microbiome-market
The human microbiome market is the industry focused on understanding and application of microbial communities living on and within the human body. Human microbiome is the aggregate of all microbiota that reside on or within human tissues or biofluids, along with the corresponding anatomical sites in which they reside, such as the GI tract, skin, mammary glands, seminal fluid, and other sites. Revolutionization of microbiome-based therapies by using AI-driven technology for enabling personalized healthcare is escalating the market growth opportunities. The increasing significance of the microbiome’s role in health and diseases, as well as advancements in microbiome analysis technologies, are significantly driving the human microbiome market. Further, the collaborative efforts between microbiome industries and organizations with an increasing number of startups and SMEs are propelling the market growth. However, complex regulatory policies and high investment required for the commercialization of human microbiome products are challenging the market.
The probiotics segment dominated the market with the largest share in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the product, the human microbiome market is divided into drugs, probiotics, prebiotics, and synbiotics. Among these, the probiotics segment dominated the market with the largest share in 2024 and is projected to grow at a substantial CAGR during the forecast period. The growing consumption of probiotic-rich foods, beverages, and supplements by consumers is driving the market growth in the probiotics segment.
The gastrointestinal segment accounted for the largest market share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the disease, the human microbiome market is divided into infectious, gastrointestinal, and endocrine & metabolic. Among these, the gastrointestinal segment accounted for the largest market share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. An increasing demand for personalized therapies, along with rising regulatory approvals and clinical pipelines, is driving the market in the gastrointestinal segment.
The live biotherapeutics segment dominated the human microbiome market in 2024 and is anticipated to grow at a significant CAGR during the forecast period.
Based on the type, the human microbiome market is divided into BCT/FMT and live biotherapeutics. Among these, the live biotherapeutics segment dominated the human microbiome market in 2024 and is anticipated to grow at a significant CAGR during the forecast period. Potential use of human microbiome for treating or preventing various conditions, including gastrointestinal disorders and metabolic conditions, is driving the market in the live biotherapeutics segment.
The hospitals & clinics segment dominated the human microbiome market in 2024 and is anticipated to grow at a significant CAGR during the forecast period.
Based on the end user, the human microbiome market is divided into hospitals & clinics and long-term care. Among these, the hospitals & clinics segment dominated the human microbiome market in 2024 and is anticipated to grow at a significant CAGR during the forecast period. An increasing application of human microbiome for the study and development of new therapies is driving the market in the hospitals & clinics segment.
North America is expected to hold the majority share of the global human microbiome market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global human microbiome market during the forecast period. The presence of well-established research infrastructure and a robust biotechnology & healthcare industry is driving the regional market growth. Further, an increasing demand for products like probiotics and prebiotics due to the prevalence of lifestyle diseases is propelling the market.
Asia Pacific is anticipated to grow at the fastest pace in the global human microbiome market during the forecast period. An increasing awareness about microbiome health and emerging healthcare and biotechnology industries, along with the government’s support for personalized medicine, are driving the market. Advancements in microbiome sequencing technology also contribute to propelling the market growth.
Europe is anticipated to hold a significant share of the human microbiome market during the forecast period. The growing prevalence of lifestyle and chronic diseases, along with the development of human microbiome therapeutics, is driving the market demand. The presence of major key players, such as Nestle, Ferring Pharmaceuticals, and Resbiotics, is contributing to propelling the market in the region.
Major vendors in the global human microbiome market are Seres Therapeutics, BiomeBank, BioHM Health Inc., Optibiotix Health plc., Infinant Health Inc., Exegi Pharma LLC, Ferring Pharmaceuticals, Seed Health, Inc., Pendulum, Actial Farmaceutica SRL, Resbiotic, Biogaia AB, Vedanta Biosciences Inc., and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Key Market Development
- In December 2024, GluCare.Health collaborated with Pendulum Therapeutics to evaluate the impact of novel next-generation probiotics on Metabolic Health. This collaboration aims to assess the effectiveness of the Pendulum Glucose Control probiotic on glycemic control, weight management, food cravings, and overall metabolic health, conducted under GluCare.Health’s unique hybrid model of care.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the human microbiome market based on the below-mentioned segments:
Global Human Microbiome Market, By Product
- Drugs
- Probiotics
- Prebiotics
- Synbiotics
Global Human Microbiome Market, By Disease
- Infectious
- Gastrointestinal
- Endocrine & Metabolic
Global Human Microbiome Market, By Type
- BCT/FMT
- Live Biotherapeutics
Global Human Microbiome Market, By End User
- Hospitals & Clinics
- Long-term Care
Global Human Microbiome Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?